"Receptors, CXCR" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemokine receptors that are specific for CXC CHEMOKINES.
Descriptor ID |
D054387
|
MeSH Number(s) |
D12.776.543.750.695.160.500 D12.776.543.750.705.852.125.500
|
Concept/Terms |
Receptors, CXCR- Receptors, CXCR
- CXC Chemokine Receptors
- Chemokine Receptors, CXC
- Receptors, CXC Chemokine
- CXC Chemokine Receptor
- Chemokine Receptor, CXC
- Receptor, CXC Chemokine
- CXCR Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR".
This graph shows the total number of publications written about "Receptors, CXCR" by people in this website by year, and whether "Receptors, CXCR" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, CXCR" by people in Profiles.
-
Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.
-
Characterization of the G-protein linked orphan receptor GPRN1/RDC1. Biochem Biophys Res Commun. 1994 May 30; 201(1):458-65.